Allergists Affirm Safety of COVID-19 Vaccines for Most
Researchers provide reassurance regarding potential allergic reactions to mRNA COVID-19 vaccinations from Pfizer and Moderna.
Immunization
As Rollout Nears, Small Practices and Rural Clinics Anticipate Challenges Storing and Administering COVID-19 Vaccines
The much-awaited remedy to the widespread transmission of SARS-CoV-2 comes with many logistical caveats.
Long-Term Immune Response With Single-Dose, Inactivated Japanese Encephalitis Vaccine
Study authors investigated the persistence of immune response with a single-dose of inactivated Japanese encephalitis vaccine and the interchangeability with a live-attenuated vaccine in healthy children aged 1 to 15 years.
Vaccine Candidate AZD1222 Effective Against COVID-19
A total of 131 cases of COVID-19 were reported in the interim analysis, with no hospitalizations or severe cases noted in participants who received the vaccine.
Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective
The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.
COVID-19 Vaccine Candidate More Than 90% Effective, Say Pfizer, BioNTech
The trial will continue as planned and final analysis is expected when the number of confirmed COVID-19 cases reaches 164.
Nurse Practitioners Prevent Spread of Diseases Among Homeless Population Through Vaccine Program
Nurse practitioners (NPs) executed a 5-step vaccination program for homeless individuals in Miami-Dade County to help reduce the spread of infectious diseases.
COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges
In the event of a likely scarcity of COVID-19 vaccines, a framework must be developed to inform who should get priority.
2018 to 2019 Vaccine Cut Influenza A-Linked Hospitalizations
The 2018 to 2019 influenza vaccine effectiveness was about 40% to 60% for reducing pediatric influenza A-associated hospitalizations.
Moderna: 30,000 Participants Enrolled in COVID-19 Vaccine Trial
The trial is investigating the efficacy, safety, and immunogenicity of mRNA-1273 at the 100mcg dose.
-
Loading...
-
Loading...
Next post in Vaccine Information Center
